Skip to main content

Navigation group

Type at least 3 characters
122 articles

Articles

Original Research

Published on 11 Sep 2024

Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous stem-cell transplantation

in Blood Cancer

  • Amalia Domingo-González
  • Rafael Alonso Fernández
  • Ana Jiménez
  • Teresa De Soto Álvarez
  • Ana Lerma-Verdejo
  • Virginia Pradillo
  • Gonzalo Benzo Callejo
  • Jose Sánchez-Pina
  • Elena Landete
  • Alberto Velasco-Valdazo
Frontiers in Hematology
doi 10.3389/frhem.2024.1438233
  • 596 views